Psychoactive Drugs Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Psychoactive Drugs stocks.

Psychoactive Drugs Stocks Recent News

Date Stock Title
May 21 AZN AstraZeneca projects $80B in revenue by 2030
May 21 AZN AstraZeneca Targets Ambitious $80B In Total Revenue By 2030 Through Pipeline Expansion
May 21 AVDL Avadel Pharmaceuticals Appoints Naseem Amin, M.D. to its Board of Directors
May 21 AZN Trending tickers: Trump Media, Palo Alto, AstraZeneca and Kingfisher
May 21 AZN AstraZeneca to establish $1.5bn ADC production site in Singapore
May 21 AZN Lowe's, Macy's, Xpeng rise premarket; Palo Alto, Zoom fall
May 21 AZN AstraZeneca Targets $80 Billion Revenue by 2030 Through Pipeline Expansion
May 21 AZN AstraZeneca shares rise as pharma group unveils 2030 revenue target
May 21 AZN AstraZeneca aims for $80 billion in total revenue by 2030
May 21 AZN AstraZeneca sets ambition to deliver $80 billion Total Revenue by 2030 and sustained growth post 2030
May 21 AZN European stocks fall on Fed rate concerns; AstraZeneca lifts revenue target
May 20 AZN Pfizer Wins $107.5M Verdict Against AstraZeneca Over Cancer Drug Patent Dispute
May 20 ENSC Sector Update: Health Care Stocks Softer Late Afternoon
May 20 AZN Amgen/AstraZeneca Say Asthma Drug Shows Activity In Another Lung Disease Across Broad Patient Population
May 20 AZN AstraZeneca, Amgen release mid-stage data on Tezspire for COPD
May 20 AZN AstraZeneca to build $1.5B ADC manufacturing plant in Singapore
May 20 AZN AstraZeneca (AZN) to Build $1.5B Cancer Drug Plant in Singapore
May 20 ENSC Ensysce Biosciences Continues Collaboration to Advance the Clinical Development of Innovative Overdose Protection Platform
May 20 FLGC Weekly Roundup on the Cannabis Sector & Psychedelic Sector
May 20 AZN Trending tickers: Gold, Ryanair, Nvidia and AstraZeneca
Psychoactive Drugs

A psychoactive drug, psychopharmaceutical, or psychotropic is a chemical substance that changes brain function and results in alterations in perception, mood, consciousness, cognition, or behavior. These substances may be used medically; recreationally; to purposefully improve performance or alter one's consciousness; as entheogens; for ritual, spiritual, or shamanic purposes; or for research. Some categories of psychoactive drugs, which have therapeutic value, are prescribed by physicians and other healthcare practitioners. Examples include anesthetics, analgesics, anticonvulsant and antiparkinsonian drugs as well as medications used to treat neuropsychiatric disorders, such as antidepressants, anxiolytics, antipsychotics, and stimulant medications. Some psychoactive substances may be used in the detoxification and rehabilitation programs for persons dependent on or addicted to other psychoactive drugs.
Psychoactive substances often bring about subjective (although these may be objectively observed) changes in consciousness and mood that the user may find rewarding and pleasant (e.g., euphoria or a sense of relaxation) or advantageous (e.g. increased alertness) and are thus reinforcing. Substances which are both rewarding and positively reinforcing have the potential to induce a state of addiction – compulsive drug use despite negative consequences. In addition, sustained use of some substances may produce physical or psychological dependence or both, associated with somatic or psychological-emotional withdrawal states respectively. Drug rehabilitation attempts to reduce addiction, through a combination of psychotherapy, support groups, and other psychoactive substances. Conversely, certain psychoactive drugs may be so unpleasant that the person will never use the substance again. This is especially true of certain deliriants (e.g. Jimson weed), powerful dissociatives (e.g. Salvia divinorum), and classic psychedelics (e.g. LSD, psilocybin), in the form of a "bad trip".
Psychoactive drug misuse, dependence and addiction have resulted in legal measures and moral debate. Governmental controls on manufacture, supply and prescription attempt to reduce problematic medical drug use. Ethical concerns have also been raised about over-use of these drugs clinically, and about their marketing by manufacturers. Popular campaigns to allow certain recreational drug use (e.g. cannabis) are also ongoing.

Browse All Tags